// App-Quantinova.ai

BSH2020‐EP‐007 : Antibody immunotherapy treatment for adults with B‐acute lymphoblastic leukaemia–a real‐world analysis

Researchers

Presenter

  • T. Dexter

Principal Investigators

  • J. Aries

  • B. Sevillano

  • J. Gribben

  • H. Oakervee

  • J. Cavenagh

  • M. Smith

  • B. Wrench

Medical Centers

  • Barts Health

  • Queen Mary University, London, UK

  • Queen Mary University of London, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Cytokine release syndrome

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 19

  • Histone-lysine N-methyltransferase 2A

  • Twist-related protein 1

Drug/Treatment

  • Inotuzumab ozogamicin

  • Blinatumomab

  • Tocilizumab

  • Allopurinol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved